Bristol-Myers Squibb Company (NYSE: BMY) started the day on April 06, 2021, with a price decrease of -1.87% at $61.98. During the day, the stock rose to $63.30 and sunk to $61.89 before settling in for the price of $63.16 at the close. Taking a more long-term approach, BMY posted a 52-week range of $54.07-$67.16.
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 20.80%. Meanwhile, its Annual Earning per share during the time was -44.40%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -298.80%. This publicly-traded company’s shares outstanding now amounts to $2.25 billion, simultaneously with a float of $2.21 billion. The organization now has a market capitalization sitting at $138.90 billion. At the time of writing, stock’s 50-day Moving Average stood at $61.69, while the 200-day Moving Average is $61.17.
While finding the extent of efficiency of the company that is accounted for 30250 employees. It has generated 1,405,554 per worker during the last fiscal year. Meanwhile, its income per employee was -298,017. The stock had 4.54 Receivables turnover and 0.34 Total Asset turnover. For the Profitability, stocks gross margin was +51.04, operating margin was +10.56 and Pretax Margin of -16.16.
Bristol-Myers Squibb Company (BMY) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Drug Manufacturers – General Industry. Bristol-Myers Squibb Company’s current insider ownership accounts for 0.10%, in contrast to 76.50% institutional ownership. According to the most recent insider trade that took place on Mar 22, this organization’s Chairman and CEO sold 25,000 shares at the rate of 62.20, making the entire transaction reach 1,555,000 in total value, affecting insider ownership by 528,980. Preceding that transaction, on Nov 25, Company’s EVP, Chief Information Officer sold 3 for 63.50, making the whole transaction’s value amount to 190. This particular insider is now the holder of 126,698 in total.
Bristol-Myers Squibb Company (BMY) Earnings and Revenue Records
In the latest quarterly report released, which was put into the public domain on 12/30/2020, the organization reported $1.46 earnings per share (EPS) for the three months, surpassing the consensus estimate (set at $1.41) by $0.05. This company achieved a net margin of -21.20 while generating a return on equity of -20.16. Wall Street market experts anticipate that the next fiscal year will bring earnings of 1.89 per share during the current fiscal year.
Bristol-Myers Squibb Company’s EPS decrease for this current 12-month fiscal period is -298.80% and is forecasted to reach 8.05 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 9.70% through the next 5 years, which can be compared against the -44.40% growth it accomplished over the previous five years trading on the market.
Bristol-Myers Squibb Company (NYSE: BMY) Trading Performance Indicators
Let’s observe the current performance indicators for Bristol-Myers Squibb Company (BMY). It’s Quick Ratio in the last reported quarter now stands at 1.50. The Stock has managed to achieve an average true range (ATR) of 1.08. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 3.27. Similarly, its price to free cash flow for trailing twelve months is now 15.06.
In the same vein, BMY’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -4.02, a figure that is expected to reach 1.82 in the next quarter, and analysts are predicting that it will be 8.05 at the market close of one year from today.
Technical Analysis of Bristol-Myers Squibb Company (BMY)
If we take a close look at the recent performances of Bristol-Myers Squibb Company (NYSE: BMY), its last 5-days Average volume was 11.5 million that shows plunge from its year to date volume of 12.78 million. During the previous 9 days, stock’s Stochastic %D was recorded 30.35% While, its Average True Range was 1.04.
Raw Stochastic average of Bristol-Myers Squibb Company (BMY) in the period of the previous 100 days is set at 39.31%, which indicates a major rise in contrast to 20.16% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 15.14% that was lower than 20.09% volatility it exhibited in the past 100-days period.